Author
Listed:
- Xiang Zhou
(Sun Yat-sen University Cancer Center)
- Su-Mei Cao
(Sun Yat-sen University Cancer Center)
- Yong-Lin Cai
(Wuzhou Red Cross Hospital)
- Xiao Zhang
(Sun Yat-sen University Cancer Center)
- Shanshan Zhang
(Sun Yat-sen University Cancer Center)
- Guo-Fei Feng
(First Affiliated Hospital of Guangxi Medical University)
- Yufeng Chen
(Karolinska Institutet)
- Qi-Sheng Feng
(Sun Yat-sen University Cancer Center)
- Yijun Chen
(Sun Yat-sen University Cancer Center)
- Ellen T. Chang
(Center for Health Sciences, Exponent
Stanford Cancer Institute)
- Zhonghua Liu
(The University of Hong Kong)
- Hans-Olov Adami
(Karolinska Institutet
University of Oslo)
- Jianjun Liu
(Agency for Science, Technology and Research (A*STAR)
National University of Singapore)
- Weimin Ye
(Karolinska Institutet
Fujian Medical University)
- Zhe Zhang
(First Affiliated Hospital of Guangxi Medical University)
- Yi-Xin Zeng
(Sun Yat-sen University Cancer Center)
- Miao Xu
(Sun Yat-sen University Cancer Center)
Abstract
Using Epstein-Barr virus (EBV)-based markers to screen populations at high risk for nasopharyngeal carcinoma (NPC) is an attractive preventive approach. Here, we develop a comprehensive risk score (CRS) that combines risk effects of EBV and human genetics for NPC risk stratification and validate this CRS within an independent, population-based dataset. Comparing the top decile with the bottom quintile of CRSs, the odds ratio of developing NPC is 21 (95% confidence interval: 12–37) in the validation dataset. When combining the top quintile of CRS with EBV serology tests currently used for NPC screening in southern China, the positive prediction value of screening increases from 4.70% (serology test alone) to 43.24% (CRS plus serology test). By identifying individuals at a monogenic level of NPC risk, this CRS approach provides opportunities for personalized risk prediction and population screening in endemic areas for the early diagnosis and secondary prevention of NPC.
Suggested Citation
Xiang Zhou & Su-Mei Cao & Yong-Lin Cai & Xiao Zhang & Shanshan Zhang & Guo-Fei Feng & Yufeng Chen & Qi-Sheng Feng & Yijun Chen & Ellen T. Chang & Zhonghua Liu & Hans-Olov Adami & Jianjun Liu & Weimin , 2021.
"A comprehensive risk score for effective risk stratification and screening of nasopharyngeal carcinoma,"
Nature Communications, Nature, vol. 12(1), pages 1-8, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25402-z
DOI: 10.1038/s41467-021-25402-z
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25402-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.